Skip to main content
Imugene Limited (ASX:IMU)
Australia flag Australia · Delayed Price · Currency is AUD
0.120
+0.005 (4.35%)
Apr 29, 2026, 4:10 PM AEST

Imugene Revenue

Imugene had revenue of 805.72K AUD in the half year ending December 31, 2025, a decrease of -90.01%. This brings the company's revenue in the last twelve months to 3.94M, down -314.40% year-over-year. In the fiscal year ending June 30, 2025, Imugene had annual revenue of 4.40M, down -11.53%.

Revenue (ttm)
3.94M
Revenue Growth
-314.40%
P/S Ratio
10.41
Revenue / Employee
262.94K
Employees
15
Market Cap
41.06M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20254.40M-573.22K-11.53%
Jun 30, 20244.97M-6.81M-57.80%
Jun 30, 202311.78M-1.19M-9.19%
Jun 30, 202212.97M5.74M79.35%
Jun 30, 20217.23M3.10M74.94%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Proteomics International Laboratories 3.21M
Avecho Biotechnology 1.24M
NeuroScientific Biopharmaceuticals 317.91K
Entropy Neurodynamics 1.58M
EZZ Life Science Holdings 61.40M
Prescient Therapeutics 4.27M
Neurizon Therapeutics 5.98M
LTR Pharma 1.13M
Revenue Rankings

Imugene News

More News